Clinical trials in special patient populations webinar is now available

By Ben Hargreaves contact

- Last updated on GMT

(Image: Getty/Photogestoeber)
(Image: Getty/Photogestoeber)

Related tags: special patient populations

Outsourcing-Pharma’s webinar on special patient populations happened this week but you still have the chance to catch-up on the discussions on demand.

Regulatory agencies require that clinical trial sponsors are able to present a summary of safety and efficacy data organized by demographic subgroups, such as age, gender and ethnicity.

In Outsourcing-Pharma’s latest webinar, which can still be accessed through the registration page​, we held a discussion on the key enablers of inclusive clinical research and how there is more that still needs to be done to ensure population demographics are fairly represented in clinical trials.

The discussion featured Annemarie Forest​, director of projects at the Clinical trials Transformation Initiative (CTTI), Christina Brennan​, VP of clinical research at The Feinstein institutes for Medical Research, and Jasmine Benger, ​senior project manger of research services at the Center for information and Study of Clinical Research Participation.

During the course of the webinar, the discussion covered the following areas:

  • Clinical trial participation and the factors affecting this
  • How the differing ages of potential participants may impact their view of trials
  • Including the patient throughout the clinical trial process
  • How to improve patient diversity and what changes have occurred in recent years
  • How technology and the generation of real-world data could improve participation

In addition to these talking points and others offered by our speakers, questions from our audience were also addressed. You can view the entire webinar on demand for free through this link​.

The webinar was enabled through the participation of our sponsors, Capsugel by Lonza Pharma & Biotech, Marken, QPS, and Synteract.

Related news

Show more

Related products

show more

A Winning End-to-End Solution for Oncology Studies

A Winning End-to-End Solution for Oncology Studies

Clinical Ink | 22-Feb-2021 | Technical / White Paper

Oncology clinical trials present a unique set of challenges for patients, study sites, and study sponsors. Using electronic patient reported outcomes (ePRO)...

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

Related suppliers

Follow us


View more